Search Results - "Desnoyer, Jill"

569 A novel microbiome-derived peptide reverses resistance to anti-PD-1 therapy by Haria, Dhwani, Ravichandar, Jayamary Divya, Desnoyer, Jill, Lau, Sabina, Lee, Jina, Rutherford, Erica, Lal, Preeti, Dabbagh, Karim, Kiefel, Helena

“…BackgroundDespite the unprecedented clinical success of immune checkpoint therapy (ICI) in many cancers there is still a large unmet need since many patients…”
Get full text

Tu1516: IDENTIFICATION AND DEVELOPMENT OF A 1ST IN CLASS NATURALLYDERIVED PROTEIN THAT DRIVES MUCOSAL HEALING AND IS ORALLY DELIVERED BY AN ENGINEERED CELLULAR THERAPY TARGETING THE GASTRO-INTESTINAL TRACT by Shilova, Irina, Chat, Chip La, Nigatu, Eskedar, Messner, Elisabeth, Desnoyer, Jill, Willcoxon, Michi, Banas, Stefanie, Ravichandar, Jayamary Divya, Narayan, Nicole, DeSantis, Todd, Dabbagh, Karim, Yamamoto, Mitsuko L.

Get full text

SELECTION OF MICROBIOME-DERIVED PEPTIDES THROUGH MULTI-TECHNOLOGY META-ANALYSIS, BINDING, AND FUNCTIONAL ASSAYS, IDENTIFIES PEPTIDES WITH THERAPEUTIC POTENTIAL THAT MODULATE IMMUNE RESPONSES AND DISEASE by Lin, Michelle, Kim, Eun Ok, Desnoyer, Jill, Narayan, Nicole, Ravichandar, Jayamary, Lau, Sabina, Hwang, Bum-Yeol, Johnson, Amy Jo, Willcoxon, Michi, DeSantis, Todd, Dabbagh, Karim, Yamamoto, Lynn

Get full text

SELECTION OF MICROBIOME-DERIVED PEPTIDES THROUGH MULTI-TECHNOLOGY META-ANALYSIS, BINDING, AND FUNCTIONAL ASSAYS, IDENTIFIES PEPTIDES WITH THERAPEUTIC POTENTIAL THAT MODULATE IMMUNE RESPONSES AND DISEASE by Lin, Michelle, Kim, Eun Ok, Desnoyer, Jill, Narayan, Nicole, Ravichandar, Jayamary, Lau, Sabina, Hwang, Bum-Yeol, Johnson, Amy Jo, Willcoxon, Michi, DeSantis, Todd, Dabbagh, Karim, Yamamoto, Lynn

“…Abstract Microbiome-driven drug discovery holds great promise for therapeutic development. However, identification of disease-associated microbiome-host…”
Get full text

Tu1173: DISCOVERING IMMUNOMODULATORY MICROBIOME-DERIVED PEPTIDES WITH THERAPEUTIC POTENTIAL THROUGH MULTITECHNOLOGY META-ANALYSIS AND FUNCTIONAL ASSAYS by Peterson, Milene, Lin, Michelle, Kim, Eun Ok, Desnoyer, Jill, Narayan, Nicole, Ravichandar, Jayamary Divya, Lau, Sabina, Hwang, Bum-Yeol, Johnson, Amy Jo, Willcoxon, Michi, DeSantis, Todd, Dabbagh, Karim, Yamamoto, Mitsuko L.

Get full text

A NOVEL MICROBIALLY-DERIVED PROTEIN CAN BE EXPRESSED IN LACTOCOCCUS LACTIS AND DELIVERED ORALLY TO IMPROVE GUT BARRIER FUNCTION AND PREVENT FIBROGENESIS BY INTERACTING WITH THE EXTRACELLULAR MATRIX DURING GI INJURY by La Chat, Chip, Nigatu, Eskedar, Messner, Elisabeth, Baeza Raja, Bernat, Desnoyer, Jill, Johnson, Amy Jo, Willcoxon, Michi, Banas, Stefanie, Han, Andrew, DeSantis, Todd, Dabbagh, Karim, Shilova, Irina, Yamamoto, Lynn

Get full text

A NOVEL MICROBIALLY-DERIVED PROTEIN CAN BE EXPRESSED IN LACTOCOCCUS LACTIS AND DELIVERED ORALLY TO IMPROVE GUT BARRIER FUNCTION AND PREVENT FIBROGENESIS BY INTERACTING WITH THE EXTRACELLULAR MATRIX DURING GI INJURY by La Chat, Chip La, Nigatu, Eskedar, Messner, Elisabeth, Raja, Bernat Baeza, Desnoyer, Jill, Johnson, Amy Jo, Willcoxon, Michi, Banas, Stefanie, Han, Andrew, DeSantis, Todd, Dabbagh, Karim, Shilova, Irina, Yamamoto, Lynn

“…Abstract Intestinal barrier dysfunction or the loss of the epithelial integrity allowing the permeation of microorganisms, dietary antigens and other particles…”
Get full text

S3356 Microbial-Derived Protein SG-2-0776 Improves Gut Barrier Function and Prevents Fibrosis by Interacting With the Extracellular Matrix During GI Injury by Raja, Bernat Baeza, La Chat, Chip, Desnoyer, Jill, Hannibal, Roberta, Johnson, Amy Jo A., Yamamoto, Lynn, Raack, Edward, Wilcoxon, Michi, Bañas, Stefanie, Chow, Cheryl-Emiliane T., Dabbagh, Karim, Han, Andrew

Get full text

Enduring attentional deficits in rats treated with a peripheral nerve injury by Higgins, Guy A., Silenieks, Leo B., Van Niekerk, Annalise, Desnoyer, Jill, Patrick, Amy, Lau, Winnie, Thevarkunnel, Sandy

“…•Rats prepared with spared nerve injury (SNI) as model of neuropathic pain.•Rats evaluated daily for 3 months post surgery for food motivation (PR schedule) or…”
Get full text

Abstract PR08: Novel microbiome-derived peptides modulate immune cell activity and the tumor microenvironment by Haria, Dhwani D., Ravichandar, Jayamary Divya, Yamamoto, Lynn, Baeza-Raja, Bernat, Bans, Ashil, Chow, Cheryl-Emiliane, Desnoyer, Jill, Dreux, Joanna, Iwai, Shoko, Lau, Sabina, Lee, Jina, Lin, Michelle, Loriaux, Paul, Narayan, Nicole, Nigatu, Eskedar, Rutherford, Erica, Wilcoxon, Michi, Wu, Yonggan, DeSantis, Todd, Takeuchi, Toshihiko, Dabbagh, Karim, Kiefel, Helena

“…Abstract The gut microbiota has emerged as an important player in cancer pathology, and increasing evidence supports its role in clinical response to immune…”
Get full text

Characterization of the 5‐HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet‐induced obesity by Higgins, Guy A., Desnoyer, Jill, Van Niekerk, Annalise, Silenieks, Leo B., Lau, Winnie, Thevarkunnel, Sandy, Izhakova, Julia, DeLannoy, Ines A.M., Fletcher, Paul J., DeLay, Josepha, Dobson, Howard

“…The 5‐HT2C receptor agonist lorcaserin (Belviq®) has been Food and Drug Administration (FDA) approved for the treatment of obesity. The present study is a back…”
Get full text

Characterization of the 5‐HT 2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet‐induced obesity by Higgins, Guy A., Desnoyer, Jill, Van Niekerk, Annalise, Silenieks, Leo B., Lau, Winnie, Thevarkunnel, Sandy, Izhakova, Julia, DeLannoy, Ines A.M., Fletcher, Paul J., DeLay, Josepha, Dobson, Howard

“…Abstract The 5‐ HT 2C receptor agonist lorcaserin (Belviq ® ) has been Food and Drug Administration (FDA) approved for the treatment of obesity. The present…”
Get full text